2alpha-methyl-19-nor-(20S)-1alpha-hyd roxy-bishomopregnacalciferol and its uses

Details for Australian Patent Application No. 2005309804 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Plum, Lori A.; Clagett-Dame, Margaret; Deluca, Hector F.; Sicinski, Rafal R.

Agent Pizzeys

Pub. Number AU-B-2005309804

PCT Pub. Number WO2006/057899

Priority 60/630,184 22.11.04 US

Filing date 18 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 29 September 2011

International Classifications

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057899 Priority application(s): WO2006/057899

29 September 2011 Application Accepted

  Published as AU-B-2005309804

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309805-17,20(Z)-dehydro vitamin D analogs and their uses

2005309793-An integrated EAS/RFID device and disabling devices therefor